JP2002505272A - 乳化剤としてガラクト脂質物質からなり、導入された活性物質の持続作用を有する水中油型局所用組成物 - Google Patents

乳化剤としてガラクト脂質物質からなり、導入された活性物質の持続作用を有する水中油型局所用組成物

Info

Publication number
JP2002505272A
JP2002505272A JP2000534188A JP2000534188A JP2002505272A JP 2002505272 A JP2002505272 A JP 2002505272A JP 2000534188 A JP2000534188 A JP 2000534188A JP 2000534188 A JP2000534188 A JP 2000534188A JP 2002505272 A JP2002505272 A JP 2002505272A
Authority
JP
Japan
Prior art keywords
substance
weight
galactolipid
emulsifier
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000534188A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002505272A5 (cg-RX-API-DMAC7.html
Inventor
アンダーシュ・カールソン
イェニ・エク
ベングト・ヘーシュレフ
イェラン・ニルソン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scotia Holdings PLC
Original Assignee
Scotia Holdings PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20410443&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2002505272(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scotia Holdings PLC filed Critical Scotia Holdings PLC
Publication of JP2002505272A publication Critical patent/JP2002505272A/ja
Publication of JP2002505272A5 publication Critical patent/JP2002505272A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/602—Glycosides, e.g. rutin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2000534188A 1998-03-06 1999-03-08 乳化剤としてガラクト脂質物質からなり、導入された活性物質の持続作用を有する水中油型局所用組成物 Pending JP2002505272A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9800729A SE9800729L (sv) 1998-03-06 1998-03-06 Ny topikal formulering I
SE9800729-7 1998-03-06
PCT/SE1999/000347 WO1999044585A1 (en) 1998-03-06 1999-03-08 Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance

Publications (2)

Publication Number Publication Date
JP2002505272A true JP2002505272A (ja) 2002-02-19
JP2002505272A5 JP2002505272A5 (cg-RX-API-DMAC7.html) 2010-04-15

Family

ID=20410443

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000534188A Pending JP2002505272A (ja) 1998-03-06 1999-03-08 乳化剤としてガラクト脂質物質からなり、導入された活性物質の持続作用を有する水中油型局所用組成物

Country Status (12)

Country Link
EP (1) EP1069886B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002505272A (cg-RX-API-DMAC7.html)
AT (1) ATE253895T1 (cg-RX-API-DMAC7.html)
AU (1) AU750526B2 (cg-RX-API-DMAC7.html)
CA (1) CA2322850A1 (cg-RX-API-DMAC7.html)
DE (1) DE69912760T2 (cg-RX-API-DMAC7.html)
DK (1) DK1069886T3 (cg-RX-API-DMAC7.html)
ES (1) ES2211062T3 (cg-RX-API-DMAC7.html)
NZ (1) NZ506756A (cg-RX-API-DMAC7.html)
PT (1) PT1069886E (cg-RX-API-DMAC7.html)
SE (1) SE9800729L (cg-RX-API-DMAC7.html)
WO (1) WO1999044585A1 (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010524860A (ja) * 2007-04-20 2010-07-22 ユニバーシティー オブ サウス オーストラリア 薬剤の皮膚送達用ナノ粒子コーティングカプセル製剤
JP2020183427A (ja) * 2014-08-27 2020-11-12 アッヴィ・インコーポレイテッド 局所製剤

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2304906A1 (en) 2000-04-07 2001-10-07 1411198 Ontario Limited 13-hode, a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
EP1151745A1 (fr) * 2000-05-05 2001-11-07 L'oreal Composition sous forme d'émulsion eau-dans-huile et ses utilisations cosmétiques
US20020165286A1 (en) * 2000-12-08 2002-11-07 Hanne Hedeman Dermal anti-inflammatory composition
JP2005535642A (ja) 2002-06-28 2005-11-24 ニトロメッド インコーポレーティッド オキシムおよび/またはヒドラゾンを含有するニトロソ化および/またはニトロシル化シクロオキシゲナーゼ−2選択的阻害剤、組成物、および使用方法
TWI397427B (zh) 2004-08-31 2013-06-01 史迪費爾研究澳洲股份有限公司 微乳化液、次微米乳化液的方法及組成物
US8449867B2 (en) 2004-08-31 2013-05-28 Stiefel Research Australia Pty Ltd Microemulsion and sub-micron emulsion process and compositions
CA2599676A1 (en) * 2005-03-04 2006-09-08 Dsm Ip Assets B.V. Foodstuff particulate lipid composition
DE102005023640A1 (de) * 2005-05-19 2006-11-23 Beiersdorf Ag Wirkstoffkombinationen aus Glucosylglyceriden und einem oder mehreren partiell neutralisierten Ester von Monoglyceriden und / oder Diglyceriden gesättigter Fettsäuren mit Zitronensäure
BRPI0616076A2 (pt) * 2005-09-16 2011-06-07 Dsm Ip Assets Bv composição farmacêutica de lipìdio particulada
HUE028588T2 (hu) 2005-12-13 2016-12-28 Incyte Holdings Corp Heteroaril-szubsztituált pirrolo[2,3-b]piridinek és pirrolo[2,3-b]pirimidinek mint Janus-kináz inhibitorok
WO2008084253A1 (en) * 2007-01-12 2008-07-17 Lipopeptide Ab Use of a galactolipid for wound and ulcer healing
RU2578430C2 (ru) 2009-11-03 2016-03-27 Липидор Аб Композиция, образующая липидный слой, для нанесения на поверхность живого организма
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
MX376856B (es) 2013-08-07 2025-03-07 Incyte Holdings Corp Formas de dosificacion de liberacion prolongada para un inhibidor de jak 1 (cinasa de janus 1).
IL316851A (en) 2015-05-21 2025-01-01 Dermavant Sciences GmbH Preparations that are pharmaceutical emulsions for topical use containing 5,3-dihydroxy-4-isopropyl-trans-stilbene and their use for the treatment or prevention of dermatological conditions or disorders
US11617724B2 (en) 2015-05-21 2023-04-04 Dermavant Sciences GmbH Topical pharmaceutical compositions
HUE050603T2 (hu) 2015-06-18 2020-12-28 Bausch Health Ireland Ltd Egy kortikoszteroidot és egy retinoidot tartalmazó topikális készítmények psoriasis kezelésére
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases

Citations (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597118A (ja) * 1982-06-16 1984-01-14 ユニリ−バ−・ナ−ムロ−ゼ・ベンノ−トシヤ−プ 化粧用組成物
JPS649908A (en) * 1987-07-02 1989-01-13 Kao Corp Cosmetic, cosmetic set and make-up method
JPH0374316A (ja) * 1989-08-11 1991-03-28 Kanebo Ltd 保湿剤
JPH04112810A (ja) * 1990-08-31 1992-04-14 Kao Corp 水性化粧料及びその製造法
JPH0543465A (ja) * 1991-08-08 1993-02-23 Mitsubishi Kasei Corp コルチコステロイド含有ローシヨン剤
JPH069365A (ja) * 1992-06-25 1994-01-18 Kanebo Ltd 皮膚化粧料
WO1996001637A1 (en) * 1994-07-12 1996-01-25 Astra Aktiebolag New pharmaceutical preparation for pain management
JPH08165244A (ja) * 1994-10-12 1996-06-25 Taisho Pharmaceut Co Ltd 皮膚疾患治療剤
WO1996024354A1 (en) * 1995-02-06 1996-08-15 Astra Aktiebolag Novel pharmaceutical composition
JPH08507768A (ja) * 1993-03-12 1996-08-20 アリス ファーマシューティカル コーポレイション 免疫仲介炎症疾患の処置のための組成物および方法
WO1997011141A1 (en) * 1995-09-22 1997-03-27 Scotia Lipidteknik Ab Fractionated vegetable oil
JPH09104614A (ja) * 1995-10-05 1997-04-22 Kanebo Ltd 皮膚化粧料
JPH09508413A (ja) * 1994-02-04 1997-08-26 スコーツイア・リピツドテクニク・アクチエボラーグ 水中油エマルジョン

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2710854B1 (fr) * 1993-10-08 1995-12-01 Oreal Emulsion huile-dans-eau utilisable pour l'obtention d'une crème.

Patent Citations (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597118A (ja) * 1982-06-16 1984-01-14 ユニリ−バ−・ナ−ムロ−ゼ・ベンノ−トシヤ−プ 化粧用組成物
JPS649908A (en) * 1987-07-02 1989-01-13 Kao Corp Cosmetic, cosmetic set and make-up method
JPH0374316A (ja) * 1989-08-11 1991-03-28 Kanebo Ltd 保湿剤
JPH04112810A (ja) * 1990-08-31 1992-04-14 Kao Corp 水性化粧料及びその製造法
JPH0543465A (ja) * 1991-08-08 1993-02-23 Mitsubishi Kasei Corp コルチコステロイド含有ローシヨン剤
JPH069365A (ja) * 1992-06-25 1994-01-18 Kanebo Ltd 皮膚化粧料
JPH08507768A (ja) * 1993-03-12 1996-08-20 アリス ファーマシューティカル コーポレイション 免疫仲介炎症疾患の処置のための組成物および方法
JPH09508413A (ja) * 1994-02-04 1997-08-26 スコーツイア・リピツドテクニク・アクチエボラーグ 水中油エマルジョン
WO1996001637A1 (en) * 1994-07-12 1996-01-25 Astra Aktiebolag New pharmaceutical preparation for pain management
JPH10502631A (ja) * 1994-07-12 1998-03-10 アストラ・アクチエボラーグ 痛みの管理のための新規な医薬製剤
JPH08165244A (ja) * 1994-10-12 1996-06-25 Taisho Pharmaceut Co Ltd 皮膚疾患治療剤
WO1996024354A1 (en) * 1995-02-06 1996-08-15 Astra Aktiebolag Novel pharmaceutical composition
JPH11504313A (ja) * 1995-02-06 1999-04-20 アストラ・アクチエボラーグ 新規な医薬組成物
WO1997011141A1 (en) * 1995-09-22 1997-03-27 Scotia Lipidteknik Ab Fractionated vegetable oil
JPH11512477A (ja) * 1995-09-22 1999-10-26 スコーツイア・リピツドテクニク・アクチエボラーグ 分別植物油
JPH09104614A (ja) * 1995-10-05 1997-04-22 Kanebo Ltd 皮膚化粧料

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010524860A (ja) * 2007-04-20 2010-07-22 ユニバーシティー オブ サウス オーストラリア 薬剤の皮膚送達用ナノ粒子コーティングカプセル製剤
JP2020183427A (ja) * 2014-08-27 2020-11-12 アッヴィ・インコーポレイテッド 局所製剤
JP2022180494A (ja) * 2014-08-27 2022-12-06 アッヴィ・インコーポレイテッド 局所製剤

Also Published As

Publication number Publication date
DE69912760D1 (de) 2003-12-18
SE9800729D0 (sv) 1998-03-06
EP1069886A1 (en) 2001-01-24
DE69912760T2 (de) 2004-09-30
CA2322850A1 (en) 1999-09-10
ATE253895T1 (de) 2003-11-15
SE9800729L (sv) 1999-09-07
NZ506756A (en) 2003-10-31
EP1069886B1 (en) 2003-11-12
PT1069886E (pt) 2004-04-30
WO1999044585A1 (en) 1999-09-10
AU3177899A (en) 1999-09-20
ES2211062T3 (es) 2004-07-01
DK1069886T3 (da) 2004-03-22
AU750526B2 (en) 2002-07-18

Similar Documents

Publication Publication Date Title
US6280752B1 (en) Vitamin E acetate-based hydrophobic gel formulation for topical application
EP1069886B1 (en) Use of a topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, for providing a prolonged effect of an incorporated active substance
JP2003533491A (ja) 薬学的及び/又は美容的組成物
US20050063930A1 (en) Topical formulation of the oil-in-water type, comprising galactolipid material as emulsifier, with a prolonged effect of an incorporated active substance
JP2017178798A (ja) 外用組成物
US20020012648A1 (en) High phospholipid-containing dermatological compositions
AU745463B2 (en) Topical formulation of oil-in-water type as a carrier for providing a reduced irritant effect
JP2002502805A (ja) 脂質混合物及びその用途
JPS61204109A (ja) 乳化型の外用組成物
US20070225234A1 (en) Topical formulation of oil-in-water type as a carrier for providing a reduced irritant effect
EP0938339B1 (en) Formulations for topical use containing vit. e acetate
JP2002505273A5 (cg-RX-API-DMAC7.html)
TW202019379A (zh) 含有亞油酸的組成物
EP3352724B1 (en) Hydrophobic gel based on vitamin e free from silicone products for topical application
EP3372221B1 (en) Hydrophobic gel based on vitamin e free from silicone products for topical application
JPH08310938A (ja) 皮膚外用剤
JPS63216815A (ja) 皮膚保護剤
JPH0529007B2 (cg-RX-API-DMAC7.html)
KR20030061852A (ko) 마이크론화된 우레아를 포함하는 수분 무함유 피부 보호제제 및 그의 제조 방법
WO2002011679A1 (en) Compositions for topical applications and production thereof

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060224

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090728

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20090929

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091015

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091022

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100128

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20100128

RD12 Notification of acceptance of power of sub attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7432

Effective date: 20100128

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20100128

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100608

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20101109